RT Journal Article
T1 Biological Biomarkers in Respiratory Diseases.
T2 Biomarcadores biológicos en las enfermedades respiratorias.
A1 García-Río, Francisco
A1 Alcázar-Navarrete, Bernardino
A1 Castillo-Villegas, Diego
A1 Cilloniz, Catia
A1 García-Ortega, Alberto
A1 Leiro-Fernández, Virginia
A1 Lojo-Rodriguez, Irene
A1 Padilla-Galo, Alicia
A1 Quezada-Loaiza, Carlos A
A1 Rodriguez-Portal, Jose Antonio
A1 Sánchez-de-la-Torre, Manuel
A1 Sibila, Oriol
A1 Martínez-García, Miguel A
K1 Apnea del sueño
K1 Asma
K1 Asthma
K1 Biomarcadores
K1 Biomarkers
K1 Bronchiectasis
K1 Bronquiectasias
K1 COPD
K1 Chronic obstructive pulmonary disease
K1 Cystic fibrosis
K1 Cáncer de pulmón
K1 Derrame pleural
K1 EPOC
K1 Embolia pulmonar
K1 Enfermedad pulmonar obstructiva crónica
K1 Fibrosis pulmonar idiopática
K1 Fibrosis quística
K1 Hipertensión arterial pulmonar
K1 Idiopathic pulmonary fibrosis
K1 Lung cancer
K1 Neumonía
K1 Pleural effusion
K1 Pneumonia
K1 Pulmonary arterial hypertension
K1 Pulmonary embolism
K1 Respiratory disorders
K1 Sleep apnea
K1 Systemic disorders
K1 Trastornos respiratorios
K1 Trastornos sistémicos
AB In recent years, personalized or precision medicine has made effective inroads into the management of diseases, including respiratory diseases. The route to implementing this approach must invariably start with the identification and validation of biological biomarkers that are closely related to the diagnosis, treatment, and prognosis of respiratory patients. In this respect, biological biomarkers of greater or lesser reliability have been identified for most respiratory diseases and disease classes, and a large number of studies are being conducted in the search for new indicators. The aim of this review is to update the reader and to analyze the existing scientific literature on the existence and diagnostic, therapeutic, and prognostic validity of the most important biological biomarkers in the main respiratory diseases, and to identify future challenges in this area.
YR 2022
FD 2022-01-17
LK http://hdl.handle.net/10668/22005
UL http://hdl.handle.net/10668/22005
LA en
LA es
DS RISalud
RD Apr 12, 2025